FreeStyle Libre 3: Abbott Sensor Based Glucose Monitoring System (FreeStyle Libre 3 System)
Study summary
The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Subject must be at least 18 years of age.
* Subject must be willing and able to provide written signed and dated informed consent.
Exclusion Criteria:
* Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes.
* Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment.
* Subject is known to be pregnant at the time of enrollment.
* Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin.
* Subject is currently on any form of treatment indicated for the treatment of diabetes.
* Subject is currently on any form of medication indicated for weight loss.
Primary outcome measure(s)
Characterize the glycemic profiles of people with and without a prediabetes diagnosis. — up to 50 days This is a data collection study.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.